How Much Did PharmID Raise?
Funding & Key Investors

PharmID has secured $1.2M in total capital, with its most recent funding round bringing in $150K through a major strategic investment. This significant backing underscores the company's progress in revolutionizing medication management and ensuring controlled substance waste integrity.

What is PharmID?

PharmID
SoftwareHealthcare SoftwareManufacturing

PharmID specializes in medication management, leveraging its proprietary WasteWitness technology to guarantee complete waste integrity in the disposal of controlled substances. The company's advanced verification system employs Raman spectroscopy and artificial intelligence to deliver accurate and rapid validation of drug waste. This technology is crucial for enhancing patient safety and ensuring stringent regulatory compliance within healthcare settings. PharmID's solutions are designed for healthcare providers, including hospitals and pharmacies, offering flexible deployment options to optimize waste verification processes. By automating documentation and tracking, PharmID aims to foster greater trust and accountability in medication disposal practices.

How much funding has PharmID raised?

PharmID has raised a total of $1.2M across 2 funding rounds:

2017

Private Equity

$1M

2020

Debt

$150K

Private Equity (2017): $1M with participation from TreeHouse Health

Debt (2020): $150K led by PPP

Key Investors in PharmID

TreeHouse Health

TreeHouse Health is a venture capital firm that appears to focus on investments within the healthcare technology and services sector, likely supporting companies that aim to improve patient outcomes and operational efficiency in medical environments.

PPP

Public-Private Partnership

Undisclosed investor

An undisclosed investor participated in this funding round, contributing to PharmID's financial backing without public disclosure of their identity or specific investment thesis.

What's next for PharmID?

With a recent major strategic investment, PharmID is poised for significant expansion and further development of its WasteWitness technology. The enterprise-level funding suggests a focus on scaling operations, potentially broadening market reach to more healthcare institutions, and enhancing the AI and spectroscopic capabilities of its verification system. This capital infusion will likely support strategic partnerships and R&D initiatives aimed at solidifying PharmID's position as a leader in medication waste integrity and compliance solutions. The company's trajectory indicates a strong emphasis on technological advancement and market penetration within the highly regulated healthcare sector.

See full PharmID company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Software industry

Financial SoftwareSoftware
Security SoftwareSoftwareNetworking Software
Engineering SoftwareSoftware
Engineering SoftwareSoftware

Frequently Asked Questions Regarding PharmID Financial Insights

What are the most recent funding rounds that PharmID has completed, and what were the funding rounds?
PharmID has recently completed 2 funding rounds: Debt on Apr 15, 2020, Private Equity on Sep 21, 2017.
What is the total amount of funding PharmID has raised to date?
PharmID has raised a total of $1.2M in funding to date.
How many funding rounds has PharmID completed?
PharmID has completed 2 funding rounds.
How much funding did PharmID raise in its most recent funding round?
PharmID raised $150K in its most recent funding round.
Who are the lead investors in PharmID's latest funding round?
The lead investor in PharmID's latest funding round was PPP. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in PharmID's history?
The largest funding round in PharmID's history was $1M.
See more information about PharmID